Evidence map›Paper›PMID 34192382›Full record

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2021

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels.

Donald MacGlashan, Santiago Alvarez-Arango, Jody Tversky

Open access · bronzeAbstract readLetter
In one paragraph

Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Efficacy of the 4 Subclasses of IgG for Interacting With CD32b/a on Human Basophils.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2025
    Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Donald MacGlashanJohns Hopkins Asthma and Allergy Center, Johns Hopkins University, Baltimore, Maryland, USA.ORCID 0000-0003-4525-0452
Santiago Alvarez-ArangoJohns Hopkins Asthma and Allergy Center, Johns Hopkins University, Baltimore, Maryland, USA.ORCID 0000-0002-4110-7221
Jody TverskyJohns Hopkins Asthma and Allergy Center, Johns Hopkins University, Baltimore, Maryland, USA.ORCID 0000-0003-3674-4143
Johns Hopkins University · US

Funding

Clinical Pharmacology Training ProgramT32GM066691 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Matthew Michael Ippolito · 2003 to 2026
$6.4M
The Role of CD32 in the Basophil Response to Specific ImmunotherapyU01AI100952 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MACGLASHAN, DONALD W · 2014 to 2018
$2.0M
Regulation of Syk Expression in Human BasophilsR01AI163043 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MACGLASHAN, DONALD W · 2021 to 2024
$1.6M
Regulation of Syk Expression in Human BasophilsR56AI139326 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MACGLASHAN, DONALD W · 2020 to 2020
$409k
The Role of CD32 in the Basophil Response to Specific ImmunotherapyR56AI100952 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MACGLASHAN, DONALD W · 2012 to 2012
$324k
NIAID NIH HHS R01 AI163043NIAID NIH HHS R56 AI100952NIAID NIH HHS R56 AI139326NIAID NIH HHS U01 AI100952NIGMS NIH HHS T32 GM066691NIH HHS T32GM066691
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Desensitization, ImmunologicHumansImmunoglobulin GRhinitis, AllergicImmunoglobulin Gallergen immunotherapybasophilsblocking antibodyCD32b

Identifiers

PMID34192382
PMCPMC9235034
OpenAlexW3177312190

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.